This is a non-core endpoint: only basic statistics are computed.
Other symptoms and signs involving the nervous and musculoskeletal systems
R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
16824
Check minimum number of events None
16824
Include endpoints None
16824
Remove individuals based on genotype QC
16341
R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
Control definitions
Control exclude
R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
R2[5-9]
Name in latin
Alia symptomata et signa ad systema nervosum et systema musculosceletale pertinentia
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Other symptoms and signs involving the nervous and musculoskeletal systems
based on the number of shared cases.
Broader endpoints:
- Symptoms and signs involving the nervous and musculoskeletal systems
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 16341 | 10023 | 6318 |
| Unadjusted prevalence (%) | 3.97 | 4.35 | 3.48 |
| Mean age at first event (years) | 51.73 | 48.72 | 56.50 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS – Other symptoms and signs involving the nervous and musculoskeletal systems
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Other symptoms and signs involving the nervous and musculoskeletal systems
↥Endpoint not on priority list, no data to show.